INTU in Stage 3 Topping with Faulty 62% Deep Base

INTU stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 3 (Topping), as of November 16, 2026 at 00:05 — CANSLIM Research
INTU is trading at 341.70 and churning around its 30-week moving average, a topping consolidation that keeps the stock in Stage 3 and roughly 48.8% below its 52-week high. The market’s focus is on a deep 45-week base with a 62.1% depth, flagged as faulty with an elevated failure rate, and no VCP contraction or volume dry-up to support a breakout. Sentiment is cautious and deteriorating, with only 2 of 8 trend-template checks passing despite a recent 27.5% run and a shallow 4.2% pullback.

INTU   Daily · data to 2026-11-13 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORTechnologyINDUSTRYSoftware – ApplicationStage 3Weinstein stage
Data to US close: Fri 13 Nov 16:00 ET = Sat 14 Nov 05:00 HKTCreated: Mon 16 Nov 00:06 HKT = 11:06 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date


Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of November 16, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.